Cystocele, Enterocele, Erectile Dysfunction, Male Sexual Dysfunction, Pelvic Floor Disorders, Pelvic Relaxation, Penile Cancer, Penile Deformities, Peyronie's Disease, Prostate Cancer, Rectocele, Scrotal Cancer, Sexual Disorders and Dysfunctions, Stress Incontinence, Urethral Cancer, Urethral Diverticulum, Urethral Fistulas, Urological Oncology, Urology, Urology / Urologic Surgery, Urology, Adult
Arthur L. Burnett, II, MD is Professor, Department of Urology, at Johns Hopkins University School of Medicine, where he is also Director of the Basic Science Laboratory in Neuro-urology. Currently, Dr. Burnett holds professional appointments at the Johns Hopkins Hospital including Director of the Male Consultation Clinic and clinician-scientist at the James Buchanan Brady Urological Institute. Dr. Burnett received his undergraduate degree in biology from Princeton University and subsequently his medical degree at Johns Hopkins University School of Medicine. He then completed his internship and residency in surgery, and subsequently residency and fellowship in urology at the Johns Hopkins Hospital. Upon completion of his urology residency, he also received an American Foundation of Urologic Disease New Investigator Award to continue research work into the regulatory mechanisms of penile erection. He has maintained an active laboratory in neuro-urology since that time.
Dr. Burnett is an established expert in the areas of: prostate cancer; lower genitourinary tract malignancies (penile, scrotal, and urethral cancers); lower genitourinary tract reconstruction (pelvic trauma and urethral stricture disease); erectile dysfunction and penile abnormalities (including Peyronies disease); and female urology (including urinary incontinence, urethral abnormalities, and prolapsed pelvic structures). This expertise is built on academic studies regarding the surgical anatomy of the pelvis, advances in surgical techniques of genital and pelvic reconstructive surgery, and basic science research contributions in the fundamental aspects of pelvic organ function.
His focus in the clinical practice of prostate cancer is reflected by his performance of over 2,000 radical prostatectomy surgeries, his application of a single, minimally invasive 3 inch incision just above the pubic bone which facilitates rapid recovery and cosmesis, his application of the nerve-sparing technique as described by Walsh, and his development of management approaches to improve postoperative functional outcomes following radical prostatectomy (see Erection Rehabilitation after Radical Prostatectomy).
Dr. Burnett is recognized for being a world-authority in the science and medicine of male erectile dysfunction. He contributed original discoveries of the nitric oxide biochemical mechanisms in erectile tissue, that paved the way for the clinical development of oral medications to treat erectile dysfunction such as Viagra. He has also pioneered work to develop therapies to protect penile nerve function required for improved erectile function recovery after radical prostatectomy.
A frequent contributor to the medical press, Dr. Burnett has written more than 150 original peer-reviewed articles, along with numerous additional articles, editorials, and book chapters, relating to his biomedical research and clinical activities. His work has appeared in many prominent journals such as Science, Nature Medicine, Proceedings of the National Academy of Sciences, Journal of Urology, Urology, and Journal of Andrology. A Fellow of the American College of Surgeons, Dr. Burnett is also a member of the American Urological Association, Sexual Medicine Society of North America, International Society for Sexual Medicine, Society of Genitourinary Reconstructive Surgeons, Society for Urodynamics and Female Urology, and the Society of Black Academic Surgeons. He has sat on various advisory committees including the Urology Study Section, National Institutes of Health Center for Scientific Review and FDA Advisory Committee for Reproductive Health Drugs.